共 50 条
Response to Katona et al.
被引:1
|作者:
Oh, Mok
[1
]
McBride, Ali
[2
]
Yun, Seongseok
[3
]
Bhattacharjee, Sandipan
[4
]
Slack, Marion
[4
]
Martin, Jennifer R.
[5
]
Jeter, Joanne
[6
,7
]
Abraham, Ivo
[4
,8
,9
]
机构:
[1] Univ Arizona, Coll Pharm, Ctr Hlth Outcomes & PharmacoEcon Res, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA
[2] Univ Arizona, Banner Univ, Coll Pharm, Dept Pharm Practice & Sci,Med Ctr,Canc Ctr, Tucson, AZ USA
[3] H Lee Moffitt Canc Ctr & Res Inst, Malignant Hematol Dept, Tampa, FL USA
[4] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Tucson, AZ 85721 USA
[5] Univ Arizona, Coll Pharm, Dept Pharm Practice & Sci, Arizona Hlth Sci Lib, Tucson, AZ 85721 USA
[6] Ohio State Univ, Coll Med, Dept Human Genet, Columbus, OH 43210 USA
[7] Ohio State Univ, Coll Med, Dept Med Oncol, Columbus, OH 43210 USA
[8] Univ Arizona, Canc Ctr, Ctr Hlth Outcomes & PharmacoEcon Res, Dept Human Genet & Med Oncol, Tucson, AZ USA
[9] Univ Arizona, Coll Med Tucson, Dept Family & Community Med, Tucson, AZ USA
来源:
关键词:
COLORECTAL-CANCER;
BRCA1;
RISK;
D O I:
10.1093/jnci/djz013
中图分类号:
R73 [肿瘤学];
学科分类号:
100214 ;
摘要:
引用
收藏
页码:524 / 525
页数:2
相关论文